Jim Daly has extensive experience in the biopharmaceutical industry, currently serving as a member of the board for multiple companies including argenx, Bellicum Pharmaceuticals, Halozyme Therapeutics, and ACADIA Pharmaceuticals since 2016. Daly also served on the board of Chimerix until January 2020 and held executive roles, including Executive Vice President and Chief Commercial Officer at Incyte Corp from 2012 to 2015, and Senior Vice President of North American Commercial Operations at Amgen from 2002 to 2011. Earlier in the career, Daly was Senior Vice President and General Manager at GSK from 1985 to 2001. Educational credentials include a Bachelor of Science in Pharmacy and an MBA from the University at Buffalo, obtained between 1979 and 1985.
This person is not in the org chart
This person is not in any teams
This person is not in any offices